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Aim: To determine the prevalence of glaucoma in the Meiktila district of central, rural Myanmar.
Methods: A cross-sectional, population-based survey of inhabitants >40 years of age from villages in
Meiktila district, Myanmar, was performed; 2481 eligible participants were identified and 2076 participated
in the study. The ophthalmic examination included Snellen visual acuity, slit-lamp examination, tonometry,
gonioscopy, dilated stereoscopic fundus examination and full-threshold perimetry. Glaucoma was classified
into clinical subtypes and categorised into three levels according to diagnostic evidence.
Results: Glaucoma was diagnosed in 1997 (80.5%) participants. The prevalence of glaucoma of any
category in at least one eye was 4.9% (95% CI 4.1 to 5.7; n = 101). The overall prevalence of primary angle-
closure glaucoma (PACG) was 2.5% (95% CI 1.5 to 3.5) and of primary open-angle glaucoma (POAG) was
2.0% (95% CI 0.9 to 3.1). PACG accounted for 84% of all blindness due to glaucoma, with the majority due to
acute angle-closure glaucoma (AACG).
Conclusion: The prevalence of glaucoma in the population aged >40 years in rural, central Myanmar was
4.9%. The ratio of PACG to POAG was approximately 1.25:1. PACG has a high visual morbidity and AACG
is visually devastating in this community. Screening programmes should be directed at PACG, and further
study of the underlying mechanisms of PACG is needed in this population.
G
laucoma is the second most common cause of world
blindness, and the majority of those blinded reside in
Asia.1 2 Recent studies have provided valuable informa-
tion about the prevalence and subtypes of glaucoma in certain
Asian regions,3–12 and it has become recognised that angle-
closure glaucoma is more common in people of Asian origin
than those with European or African ethnicity5 13–16; however,
the relative rates of open-angle to closed-angle glaucoma are
region-dependent within Asia, with the rate of primary angle-
closure glaucoma (PACG) particularly high in Mongolian and
Chinese eyes,5 8 17 and variable across India.6 10–12 18 In accor-
dance with the World Health Organization’s (WHO’s) Vision
20/20 initiative, the assessment of the prevalence of glaucoma
subtypes is important because it has implications for the
optimisation of screening programmes and treatment strate-
gies.19–23
WHO estimates of the prevalence of glaucoma in many Asian
regions are crude. Limited WHO data24 and anecdotal evidence
suggested high rates of angle-closure glaucoma in the Union of
Myanmar (Myanmar; formerly Burma). Until now, no robust
population-based data have been available on the prevalence
and subtypes of glaucoma in Myanmar. Here, we report on the
prevalence and subtypes of glaucoma in the inhabitants of the
rural, central region of this country.
METHODS
Sampling procedure
The Meiktila Eye Study (MES) was a population-based, cross-
sectional ophthalmic survey of the inhabitants of rural villages
in central Myanmar. The principal aims of this project were to
estimate the prevalence and causes of visual impairment, and
the prevalence and risk factors of ocular disorders, including
glaucoma, among persons >40 years of age in this region.
The study was conducted within the Mandalay Division, an
area encompassing 34 253 km2 divided into seven second-order
administrative districts of approximately equal size. The town-
ship of Meiktila (population approximately 251 000), located at
20 5˚39N, 95 5˚39 E, lies centrally in the Meiktila District, and is
the only urban region in this entire district. The District is
arbitrarily divided by the Ministry of Health (MOH) into six
zones served by a centrally located eye hospital in Meiktila.
Participants were selected using a randomised, stratified,
cluster sampling process. A sampling frame consisting of a list
of all villages in the Meiktila District along with their
populations was obtained from the MOH. Villages were
arbitrarily stratified as large (population .825) or small
(population (825), with small villages in each of the six zones
within the Meiktila District constituting six separate strata. For
logistical reasons, sampling was restricted to villages within 3 h
drive from Meiktila (an area encompassing approximately 80%
of the district). All persons aged >40 years from each selected
village were eligible for inclusion. The sample size was based on
the desired precision of the estimate of blindness (the principal
aim of the MES); the assessment of glaucoma prevalence was a
secondary objective. Healthcare workers from Meiktila town-
ship enumerated the selected villages (and advertised and
promoted the survey) before commencement of the survey. Six
small villages (one from each zone) and four large villages were
enumerated, providing a total sample population of 2481
people.
Data collection
Data collection was performed at the end of the rainy season in
November 2005. A single survey team conducted the entire
study. Each team member was assigned specific tasks and was
well trained in the appropriate area. Specific observations were
done by 1–2 members, limiting or eliminating interobserver
Abbreviations: AACG, acute angle-closure glaucoma; CDR, cup/disc
ratio; FDT, frequency doubling technology; IOP, intraocular pressure;
ISGEO, International Society for Geographic and Epidemiological
Ophthalmology; MES, Meiktila Eye Study; MOH, Ministry of Health;
PACG, primary angle-closure glaucoma; POAG, primary open-angle
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variability. All equipment and personnel were transported to
each village, and the data collection was performed on site. A
medical and ophthalmic history was obtained from each patient
in his or her own language by qualified healthcare workers.
Each participant then received a comprehensive vision and eye
examination.
Visual acuity (VA) was tested unaided, and with a pinhole
using a well-illuminated Snellen chart at 6 m. Intraocular
pressure (IOP) was measured with a Goldmann applanation
tonometer (Haag-Streit, Koeniz, Switzerland) and anterior
segment examination was performed using a slit lamp. The
presence of previous iris ischaemia or pseudoexfoliation was
recorded. Gonioscopy was performed by two experienced
ophthalmologists using a Sussman goniolens. Static gonioscopy
was performed in dim illumination with minimal pressure on
the cornea using a short slit beam; each quadrant was graded
using the Scheie classification. If .90˚ of posterior trabecular
meshwork (TM) was visible, the pupil was dilated with
tropicamide 1% and phenylephrine 2.5%. Eyes with (90˚ of
posterior TM visible were deemed ‘‘occludable’’ and dilated
with tropicamide 0.5% only and kept under observation for 4 h;
if not possible, they were not dilated. If either eye had evidence
of previous acute angle-closure glaucoma (AACG; see definition
below), then neither eye was dilated. Optic disc and retinal
examination was performed by two experienced ophthalmol-
ogists using a 78 D lens and reference to standard disc images.
The vertical cup:disc ratio (CDR) and the presence of focal
notching were recorded. The agreement between the two
ophthalmologists was good for grading the occludability
(k) = 0.78 and determining the CDR (k) = 0.72.
Eyes with VA .6/60, and which fulfilled category 1 optic disc
criteria (see below), underwent full-threshold perimetry (C-20
strategy) using frequency doubling technology (FDT; Zeiss
Humphrey Systems, Dublin, California, USA). Tests were
considered reliable if there were ,20% fixation errors and
,33% false-positive and false-negative errors. All individuals
were naı¨ve to perimetry and received instruction in their own
language, followed by a practice in the demonstration mode. If
the initial test was unreliable, individuals were given a second
attempt. More than one missed point on the pattern deviation
was considered abnormal.25
Ethics
The MES was approved by the MOH in Myanmar and had
ethical approval from the Royal Adelaide Hospital Ethics
Committee. Consent for participation was obtained from the
head of each village before commencement of the survey, and
written, informed consent, in the participant’s own language,
was obtained from all willing participants. The study was
conducted in accordance with the Declaration of Helsinki.
Statistics
Prevalence rates were calculated as ratio estimates using
appropriate weights for each of the sampled villages.
Bootstrapping was used to overcome the problem of variance
estimation in clusters where only the one primary sampling
unit (village) was selected. All prevalence estimates were
calculated using SAS V.9.1. Villages were randomly selected;
hence, point prevalences are unbiased.
Definitions
A three-tiered system of evidence, as suggested by the
International Society for Geographic and Epidemiological
Ophthalmology (ISGEO),26 was used to categorise glaucoma
(box 1).
Blindness due to glaucoma was defined as an eye with
pinhole vision ,3/60; fields were not taken into consideration.
Prevalence was calculated on an individual rather than a per
eye basis. If at least one eye was diagnosable using the above
criteria, the subject was included in the prevalence analysis. In
those participants with only one diagnosable eye, if glaucoma
was not present in this eye, they were assumed not to have
glaucoma in the undiagnosable eye.
Glaucoma was also categorised into three principal clinical
subtypes:
1. PACG was diagnosed if the criteria for category 1–3 were
met, (90˚ of posterior TM was visible with static
gonioscopy and no secondary cause for glaucoma was
present. PACG was further subdivided into acute and
chronic forms. Chronic PACG was diagnosed if the above
criteria were met, and acute PACG was diagnosed if the
above criteria were met and there was evidence of previous
iris ischaemia (defined as the presence of iris whorling or
stromal atrophy).27 Historical evidence only of an attack of
AACG was considered insufficient for diagnosis.
2. Primary open-angle glaucoma (POAG) was diagnosed if the
criteria for category 1–3 were met, .90˚ of posterior TM
Box 1 Diagnostic criteria for glaucoma
N Category 1 diagnosis (structural and functional evi-
dence): eyes with a cup:disc ratio (CDR) .97.5th centile
for the normal (non-glaucomatous) population (CDR
>0.7 was used on the basis of the data from previous
studies in the region), or a CDR >0.6 in the presence of
asymmetry >0.3 or a neuroretinal rim width reduced to
,0.1 CDR (between 11:00 and 13:00 or between 17:00
and 19:00 h) and a definite visual field defect consistent
with glaucoma. Eyes with evidence of previous acute
angle-closure glaucoma (AACG) which had no percep-
tion of light (NPL) were also classified as category 1, even
if the optic disc was not visualised (‘‘end-stage’’ AACG).
N Category 2 diagnosis (advanced structural damage with
unproved field loss): if the subject could not satisfactorily
complete visual field testing, but had a CDR .99.5th
centile for the normal (non-glaucomatous) population
(CDR >0.8 was used on the basis of the data from the
normal population in this study), glaucoma was diag-
nosed solely on the basis of structural evidence.
N Category 3 diagnosis (optic disc not seen; field test
impossible): if it was not possible to examine the optic
disc, glaucoma was diagnosed if: (A) the visual acuity
(VA) was ,3/60 and the intraocular pressure .99.5th
centile; or (B) the VA was ,3/60 and the eye showed
evidence of glaucoma-filtering surgery.
Table 1 Intraocular pressure in normal participants*
Right IOP (mm Hg)
(95% CI)





Mean 14.8 (14.65 to 14.95) 14.9 (14.75 to 15.05)
Median 14 15
97.5th centile 21.7 (21.55 to 21.85) 21.9 (21.75 to 22.05)
99.5th centile 25.0 (24.85 to 25.15) 25.4 (25.25 to 25.55)
IOP, intraocular pressure.
*Subjects had neither structural nor functional evidence of glaucomatous
optic neuropathy.
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was visible on static gonioscopy and no secondary cause for
glaucoma was present.
3. Secondary glaucoma was diagnosed if the criteria for
category 1–3 were met and a secondary cause was evident.
This included pseudoexfoliative and neovascular glaucoma.
RESULTS
A total of 2481 participants were eligible and 2076 were
examined (836 men, 1240 women; participation rate 83.7%).
The mean age was 56.2 years. Sufficient examination data to
diagnose glaucoma (as defined above) in at least one eye were
obtained from 1997 participants. There were 110 participants in
whom glaucoma was diagnosable in one eye only. The mean
IOP and CDR for the normal (non-glaucomatous) population
are shown in tables 1 and 2, respectively. There were seven eyes
which had end-stage AACG and were classified in category 1.
The prevalence of glaucoma (allowing for the study design)
in any category in at least one eye was 4.9% (95% CI 4.1 to 5.7;
n = 101 participants). There were 156 eyes of 101 participants
which met the ISGEO three-tiered evidence-based classification
of glaucoma: 51 eyes were in category 1, 73 were in category 2
(perimetry not performed or unreliable) and 32 were in
category 3. Of the 73 eyes in category 2, 46 did not meet the
VA criteria (VA .6/60) and the remainder could not perform
reliable (as defined above) perimetry by the second attempt.
Seven eyes met the structural definitions of criteria 1, but did
not meet the VA standard for perimetry or could not perform
reliable perimetry, and were deemed non-glaucomatous. Only
three eyes were classified as glaucomatous on the basis of CDR
asymmetry.
The prevalence of glaucoma increased with age in both men
and women (fig 1). Figure 2 shows the distribution of PACG,
POAG and secondary glaucoma in men and women. The overall
prevalence of PACG was 2.5% (95% CI 1.5 to 3.5) and of POAG
was 2.0% (95% CI 0.9 to 3.1). In all, 22 (1.1%) participants had
AACG in at least one eye and 30 (1.5%) had CACG. There were
10 (0.5%) participants with secondary glaucoma in at least one
eye: 5 eyes with pseudoexfoliative, 3 with uveitic and 2 with
neovascular glaucoma.
There were 32 eyes blinded by PACG, accounting for 84% of
all eyes with blindness due to glaucoma. AACG was the cause
of blindness in 20 eyes, and CACG in 12 eyes. Eight participants
were bilaterally blind due to AACG and three due to CACG.
Only three eyes were blind due to POAG and four due to
secondary glaucoma.
The use of mydriatics, as per the protocol, produced no
adverse events.
DISCUSSION
This study provides the first population-based data about the
prevalence and subtypes of glaucoma in Myanmar. Data
relating to the prevalence of ‘‘occludable’’ angles (angle-closure
glaucoma suspects) are not presented in this report. The most
striking finding was the high prevalence of PACG in this
population. The ratio of PACG to POAG was 1.25:1, which is
lower than the 3:1 ratio reported in a Mongolian population,5
but almost twice that reported in Chinese eyes,3 8 and
considerably greater than the ratios reported in populations
from India and Bangladesh (table 3).6 7 Discerning the relative
amounts of PACG to POAG is important because it has
profound implications in the optimisation of screening and
treatment strategies: a greater prevalence of PACG, coupled
with its high visual morbidity, implies that more resources
should be directed towards it. A directed screening programme
involving Van Herick grading, gonioscopy and laser iridotomy
has been highly successful in reducing angle-closure glaucoma
in the Inuit and is undergoing evaluation in Mongolia.19
However, evidence is emerging which suggests that the
mechanism of angle closure in certain regions of Asia, including
South-East Asia, may be multifactorial, involving pupillary
block and non-pupillary block components.19 28
Although we recognise that consistency among epidemiolo-
gical studies is important and have modelled this study, as
much as practically possible, on similar studies from this
region,3 6–8 we chose to slightly modify the ISGEO inclusion
criteria: we included eyes with no perception of light (NPL;
with evidence of old AACG) in which the optic disc was not
seen, irrespective of the IOP, and which did not meet the
criteria for classification in the current ISGEO system. In our
opinion, these eyes have evidence of severe functional and
implied structural optic neuropathy secondary to an old acute
Table 2 Vertical cup:disc ratio in normal participants*
Right CDR Left CDR
Number of measurements 1850 1852
Mean 0.34 0.34
Median 0.3 0.3
97.5th centile 0.64 0.66
99.5th centile 0.79 0.82
CDR, cup:disc ratio.
*Defined as those with available vertical CDR data and excluding eyes with
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Figure 2 Distribution of clinical glaucoma subtypes by gender.
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IOP increase and warrant classification in category 1. However,
even if these eyes were excluded from the analysis, the overall
prevalence (4.7%) is minimally affected.
The prevalence of glaucoma in this study is a little higher
than prevalence rates reported in other population-based
studies from Asia3 5–9 (table 3). This may partly relate to the
use of FDT perimetry, with relatively high sensitivity, and to the
inclusion of eyes with old AACG. However, it may simply reflect
a particularly high rate of PACG in this population.
Most of those eyes that were not adequately examined for
glaucoma, had dense cataracts. Some of these eyes could also
have had glaucoma so that the overall estimate for the
prevalence of glaucoma (4.9%) may, in fact, be conservative.
The 97.5th centile for the CDR in the normal population was
approximately 6.5; however, based on recent data from this
region a CDR of >0.7 was chosen as the cut-off for field testing;
hence, early glaucoma with concentric cupping could have been
missed. It is also likely that many of the participants classified
as having PACG actually had combined-mechanism glaucoma;
however, relationships between the amount of angle closure
and the IOP, which may arouse suspicion of a combined
mechanism, were not taken into consideration in this study.
The optimal method of perimetry for studies of this nature
conducted ‘‘in the field’’ is unclear. We chose to use FDT
because of its availability, portability, relative impunity to
defocus,29 ease of use and recent use in a similar population-
based study in India.4 10 The current study was designed to
detect glaucoma based on ISGEO criteria; hence, perimetry was
only designated for those participants at least meeting the
category 1 structural criteria. An arbitrary VA cut-off for
perimetry was set at presenting Snellen acuity .6/60. Even at
this level, almost 63% of eyes in category 2 were not eligible for
perimetry, hence the relatively low rate (25%) of reliable
perimetric data on the population meeting other diagnostic
criteria. Previous similar studies4 10 using FDT had set the VA
limit at 6/24; however, given that the FDT sensitivity suffers
little from up to 6 D of defocus,29 and the high prevalence of
visual impairment in this population, our VA criterion seems
reasonable. Arguably, the low rate of reliable perimetric data
casts doubt on the prevalence of glaucoma; however, the ISGEO
guidelines for the diagnosis of glaucoma are deliberately
weighted towards structural changes, because it is well
recognised that reliable perimetry in population-based studies,
particularly in the developing world, is difficult.
Although the participation rate was relatively high (83%), we
have no robust data about the visual status and ocular health of
the non-participants. Anecdotally (according to the village
chiefs), the principal reason for non-participation was occupa-
tion-related; hence, it is unlikely that any of the non-
participants were glaucoma blind, suggesting that the
prevalence of glaucoma in this group would be lower than in
the participants. Although accurate data about the gender
distribution in the Meiktila district were not available, it is
likely that women were over-represented in this study (59%), a
common occurrence among similar studies, possibly reflecting
occupation-related availability.
The Meiktila District was chosen for logistical reasons, not
randomly, and may not be representative of neighbouring
regions within the Mandalay Division of central Myanmar;
however, we have no reason to believe that this is the case.
In conclusion, the prevalence of glaucoma in the population
>40 years of age in the Meiktila District of rural, central
Myanmar is 4.9%. The ratio of PACG to POAG is approximately
1.25:1. Given the high visual morbidity of PACG, screening
programmes should be directed at this disease and further
study of the underlying mechanisms of PACG in this popula-
tion is needed.
ACKNOWLEDGEMENTS
We thank the Myanmar Ministry of Health for their invaluable
assistance with this survey. This study was possible only due to the
support of the staff at the Yangon Eye Hospital and Meiktila Eye
Hospital. Expert assistance was provided by Drs Tun Aung Kyaw and
Nyunt Maung from the Trachoma Control and Prevention of Blindness
Program. Thanks to Paul Foster for generous and expert advice
concerning the methodology and technical aspects. Australian
Ambassador to Yangon, Bob Davis, provided valuable assistance and
donated a slit lamp to the Meiktila Eye Hospital. We thank Alcon
Australia for the loan of equipment. The sole financial support was
provided by a generous grant from Pfizer Ophthalmic. We thank the
people who participated in this study and who welcomed us so kindly
into their villages.
Authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . .
R J Casson, H S Newland, J Muecke, S McGovern, L Abraham, D Selva,
Department of Ophthalmology and Visual Sciences, South Australian
Institute of Ophthalmology, Adelaide University, Adelaide, South Australia,
Australia
W K Shein, Meiktila Eye Hospital and Trachoma Control and Prevention
Programme, Meiktila, Myanmar
T Aung, Yangon Eye Hospital, Yangon, Myanmar
Funding: The survey was funded by a grant from Pfizer Ophthalmic. The
design of the survey, its execution, analysis, interpretation and publication
were carried out independently by the authors.
Competing interests: None.
REFERENCES
1 Quigley HA, Broman AT. The number of people with glaucoma worldwide in
2010 and 2020. Br J Ophthalmol 2006;90:262–7.
2 Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in
the year 2002. Bull World Health Organ 2004;82:844–51.
3 He M, Foster PJ, Ge J, et al. Prevalence and clinical characteristics of glaucoma in
adult Chinese: a population-based study in Liwan district, Guangzhou. Invest
Ophthalmol Vis Sci 2006;47:2782–8.
4 Vijaya L, George R, Arvind H, et al. Prevalence of angle-closure disease in a
rural southern Indian population. Arch Ophthalmol 2006;124:403–9.
Table 3 Prevalence of glaucoma in various Asian populations






of POAG Ratio POAG:PACG
He et al,3 2006 Liwan, Guangzhou 1405 >50 1.5% 2.1% 0.71:1
Vijaya et al,4 10 2005, 2006 Chennai, India 3924 >40 0.87% 1.62% 0.54:1
Raychaudhuri et al,6 2005 Calcutta, India 1269 >50 0.72% 3.6% 0.2:1
Rahman et al,7 2004 Dhaka, Bangladesh 2346 >35 0.4% 2.5% 0.16:1
Foster et al,8 2000 Tanjong Pagar,
Singapore
1232 40–79 1.13% 1.78% 0.63:1
Dandona et al,11 12 2000 Hyderabad, India 1399 >40 1.08% 2.56% 0.41:1
Present study Meiktila, Myanmar 1997 >40 2.5% 2.0% 1.25:1
PACG, primary angle-closure glaucoma; POAG, primary open-angle glaucoma.
Prevalence of glaucoma in rural Myanmar 713
www.bjophthalmol.com
 on 12 May 2008 bjo.bmj.comDownloaded from 
5 Foster PJ, Baasanhu J, Alsbirk PH, et al. Glaucoma in Mongolia. A population-
based survey in Hovsgol province, northern Mongolia. Arch Ophthalmol
1996;114:1235–41.
6 Raychaudhuri A, Lahiri SK, Bandyopadhyay M, et al. A population based survey
of the prevalence and types of glaucoma in rural West Bengal: the West Bengal
Glaucoma Study. Br J Ophthalmol 2005;89:1559–64.
7 Rahman MM, Rahman N, Foster PJ, et al. The prevalence of glaucoma in
Bangladesh: a population based survey in Dhaka division. Br J Ophthalmol
2004;88:1493–7.
8 Foster PJ, Oen FT, Machin D, et al. The prevalence of glaucoma in Chinese
residents of Singapore: a cross-sectional population survey of the Tanjong Pagar
district. Arch Ophthalmol 2000;118:1105–11.
9 Bourne RR, Sukudom P, Foster PJ, et al. Prevalence of glaucoma in Thailand: a
population based survey in Rom Klao District, Bangkok. Br J Ophthalmol
2003;87:1069–74.
10 Vijaya L, George R, Paul PG, et al. Prevalence of open-angle glaucoma in a rural
south Indian population. Invest Ophthalmol Vis Sci 2005;46:4461–7.
11 Dandona L, Dandona R, Mandal P, et al. Angle-closure glaucoma in an urban
population in southern India. The Andhra Pradesh Eye Disease Study.
Ophthalmology 2000;107:1710–16.
12 Dandona L, Dandona R, Srinivas M, et al. Open-angle glaucoma in an urban
population in southern India: the Andhra Pradesh Eye Disease Study.
Ophthalmology 2000;107:1702–9.
13 Salmon JF, Mermoud A, Ivey A, et al. The prevalence of primary angle closure
glaucoma and open angle glaucoma in Mamre, western Cape, South Africa.
Arch Ophthalmol 1993;111:1263–9.
14 Foster PJ. The epidemiology of primary angle closure and associated
glaucomatous optic neuropathy. Semin Ophthalmol 2002;17:50–8.
15 Bourne RR, Sorensen KE, Klauber A, et al. Glaucoma in East Greenlandic Inuit—
a population survey in Ittoqqortoormiit (Scoresbysund). Acta Ophthalmol Scand
2001;79:462–7.
16 Chew PT, Aung T. Primary angle-closure glaucoma in Asia. J Glaucoma
2001;10:S7–8.
17 Foster PJ, Johnson GJ. Glaucoma in China: how big is the problem?
Br J Ophthalmol 2001;85:1277–82.
18 Thulasiraj RD, Nirmalan PK, Ramakrishnan R, et al. Blindness and vision
impairment in a rural south Indian population: the Aravind Comprehensive Eye
Survey. Ophthalmology 2003;110:1491–8.
19 Johnson GJ, Foster PJ. Can we prevent angle-closure glaucoma? Eye
2005;19:1119–24.
20 Aung T, Chew PT. Review of recent advancements in the understanding of
primary angle-closure glaucoma. Curr Opin Ophthalmol 2002;13:89–93.
21 Nolan WP, Aung T, Machin D, et al. Detection of narrow angles and established
angle closure in Chinese residents of Singapore: potential screening tests.
Am J Ophthalmol 2006;141:896–901.
22 Friedman DS, Gazzard G, Foster P, et al. Ultrasonographic biomicroscopy,
Scheimpflug photography, and novel provocative tests in contralateral eyes of
Chinese patients initially seen with acute angle closure. Arch Ophthalmol
2003;121:633–42.
23 Saw SM, Gazzard G, Friedman DS. Interventions for angle-closure glaucoma:
an evidence-based update. Ophthalmology 2003;110:1869–78.
24 Alsbirk PH. Prevention and control of visual impairment and blindness (with
special reference to glaucoma) in Burma, Consultant Report.World Health
Organization, Southeast Asia Region/Ophthalmology, 1984.
25 Muskens RP, Heeg GP, Jansonius NM. An evaluation of algorithms designed to
classify the results from frequency doubling perimetry. Ophthalmic Physiol Opt
2004;24:498–503.
26 Foster PJ, Buhrmann R, Quigley HA, et al. The definition and classification of
glaucoma in prevalence surveys. Br J Ophthalmol 2002;86:238–42.
27 Loon SC, Chew PT, Oen FT, et al. Iris ischaemic changes and visual outcome after
acute primary angle closure. Clin Experiment Ophthalmol 2005;33:473–7.
28 Aung T, Nolan WP, Machin D, et al. Anterior chamber depth and the risk of
primary angle closure in 2 East Asian populations. Arch Ophthalmol
2005;123:527–32.
29 Anderson AJ, Johnson CA. Frequency-doubling technology perimetry and
optical defocus. Invest Ophthalmol Vis Sci 2003;44:4147–52.
VIDEO REPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Descemet-Stripping Automated Endothelial Keratoplasty Technique in Patients with
Anterior Chamber Intraocular Lenses
Brian Groat, Michelle S Ying, David T Vroman, Luis E Ferna´ndez de Castro
Storm Eye Institute, Medical University of South Carolina, Charleston, SC, USA
ABSTRACT
Background: Descemet-Stripping Automated Endothelial Keratoplasty (DSAEK) is a relatively
new, but proven procedure in treating endothelial dysfunction. Patients with aphakia or anterior
chamber intraocular lenses (ACIOL) pose more of a challenge when performing DSAEK. We
report a technique that can be used during DSAEK to address situations.
Case Report: An 80-year-old white female with a history of intracpsular cataract extraction
and a secondary ACIOL in her left eye was referred with pseudophakic bullous keratopathy and
3+ stromal edema. DSAEK was performed with two modifications: 1) occlusive pupilloplasty,
and 2) a fixation suture to stabilize the donor tissue during the unfolding process. Her two-week
postoperative visual acuity was 20/60.
Video: The surgical video demonstrates the modified DSAEK technique. A 10-0 polypropylene
suture was used to create the occlusive pupilloplasty with a slipknot. The endothelium and
Descemet were stripped using a 90-degree scraper. The donor tissue was folded in a 60/40 taco
fashion and inserted into the anterior chamber. To stabilize the graft while unfolding in a
shallow anterior chamber, a fixation suture was placed in the inferior portion of the graft. Air
was injected, and the tissue unfolded in good position with the Lindstrom roller, and finally the
occlusive pupilloplasty was released.
Comment: Currently, some patients with ACIOL are managed by performing an intraocular
lens exchange with a scleral-sutured lens followed 6-8 weeks later by DSAEK. However, the two
modifications described above allows DSAEK to be performed successfully in a single procedure
with minimal additional surgical time.
To view the full report and accompanying video please go to: http://bjo.bmj.com/cgi/content/
full/91/6/714/DC1
All videos from the BJO video report collection are available from: http://bjo.bmj.com/video/
collection.dtl
Br J Ophthalmol 2007;91:714. doi: 10.1136/bjo.2007.121343
714 Casson, Newland, Muecke, et al
www.bjophthalmol.com
 on 12 May 2008 bjo.bmj.comDownloaded from 
